Terms: = Colorectal cancer AND BRCA2, FAD, 675, ENSG00000139618, FACD, FAD1, FANCD, FANCD1, BRCC2, RP11-298P3_4 AND Treatment
18597 results:
1. Second Chance for Cure: Stereotactic Ablative Radiotherapy in Oligometastatic Disease.
Salim N; Tumanova K; Popodko A; Libson E
JCO Glob Oncol; 2024 May; 10():e2300275. PubMed ID: 38754052
[TBL] [Abstract] [Full Text] [Related]
2. Value of Real-World Evidence for treatment Selection: A Case Study in Colon cancer.
Shen L; van Gestel A; Prinsen P; Vink G; van Erning FN; Geleijnse G; Kaptein M
JCO Clin Cancer Inform; 2024 May; 8():e2300186. PubMed ID: 38753347
[TBL] [Abstract] [Full Text] [Related]
3. Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathways.
Kurmasheva N; Said A; Wong B; Kinderman P; Han X; Rahimic AHF; Kress A; Carter-Timofte ME; Holm E; van der Horst D; Kollmann CF; Liu Z; Wang C; Hoang HD; Kovalenko E; Chrysopoulou M; Twayana KS; Ottosen RN; Svenningsen EB; Begnini F; Kiib AE; Kromm FEH; Weiss HJ; Di Carlo D; Muscolini M; Higgins M; van der Heijden M; Bardoul A; Tong T; Ozsvar A; Hou WH; Schack VR; Holm CK; Zheng Y; Ruzek M; Kalucka J; de la Vega L; Elgaher WAM; Korshoej AR; Lin R; Hiscott J; Poulsen TB; O'Neill LA; Roy DG; Rinschen MM; van Montfoort N; Diallo JS; Farin HF; Alain T; Olagnier D
Nat Commun; 2024 May; 15(1):4096. PubMed ID: 38750019
[TBL] [Abstract] [Full Text] [Related]
4. Gene mutation profiling in microsatellite instability colorectal cancer and its association with the efficacy of immunotherapy: A retrospective study.
Liu Y; Cui K; Ma W
Cancer Med; 2024 May; 13(9):e6910. PubMed ID: 38746969
[TBL] [Abstract] [Full Text] [Related]
5. Quality of Life in Patients Undergoing Emergency Surgery for Complex colorectal cancer: Protocol and Piloting of the Surgical Utilization and Recovery Patterns for Advanced Stage colorectal cancer Study.
Ciubotaru C; Poenaru RC; Beuran M; Pătraşcu T; Turculeţ CȘ; Constantinescu G; Hostiuc S; Moldoveanu A; Negoi I
Chirurgia (Bucur); 2024 Apr; 119(2):156-170. PubMed ID: 38743829
[No Abstract] [Full Text] [Related]
6. Examining variations in body composition among patients with colorectal cancer according to site and disease stage.
da Silva Nascimento ML; Alves Bennemann N; de Sousa IM; de Oliveira Bezerra MR; Villaça Chaves G; Moreira Lima Verde SM; Fernandes Maurício S; Barreto Campello Carvalheira J; Santos Mendes MC; Miranda AL; da Costa Pereira JP; Gonzalez MC; Prado CM; Fayh APT
Sci Rep; 2024 May; 14(1):10829. PubMed ID: 38734789
[TBL] [Abstract] [Full Text] [Related]
7. Analysis of risk characteristics for early progression and late progression in locally advanced rectal cancer patients: a large population-based and validated study.
Yu Y; Wu H; Qiu J; Wu S; Gan Y; Shao L; Lin C; Hong L; Wu J
Support Care Cancer; 2024 May; 32(6):340. PubMed ID: 38733415
[TBL] [Abstract] [Full Text] [Related]
8. An In Vitro Study on the Cytotoxic, Antioxidant, and Antimicrobial Properties of Yamogenin-A Plant Steroidal Saponin and Evaluation of Its Mechanism of Action in Gastric cancer Cells.
Stefanowicz-Hajduk J; Graczyk P; Hering A; Gucwa M; Nowak A; Hałasa R
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731847
[TBL] [Abstract] [Full Text] [Related]
9. Efficacy of surgical treatment of perianal infection in patients with hematological malignancy.
He J; Ni Z; Li Z
Medicine (Baltimore); 2024 May; 103(19):e38082. PubMed ID: 38728504
[TBL] [Abstract] [Full Text] [Related]
10. Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial.
Wang DS; Ren C; Li SS; Fong WP; Wu XJ; Xiao J; Li BK; Zheng Y; Ding PR; Chen G; Qiu MZ; Wang ZQ; Wang FH; Luo HY; Wang F; Wang XZ; Wang LY; Xie DJ; Chen T; Li LR; Lu ZH; Zhai XH; Liu TS; Yuan Y; Chen JQ; Tan Q; Pan ZZ; Wan DS; Zhang R; Yuan YF; Xu RH; Li YH
PLoS Med; 2024 May; 21(5):e1004389. PubMed ID: 38728364
[TBL] [Abstract] [Full Text] [Related]
11. Malnutrition as an unfavorable prognostic factor after surgical treatment for metastatic colorectal cancer.
Skroński M; Olszewska N; Nyckowski P; Ukleja A; Lisowska J; Słodkowski M; Szczygieł B
Pol Przegl Chir; 2024 Mar; 96(3):1-8. PubMed ID: 38721641
[TBL] [Abstract] [Full Text] [Related]
12. Preoperative three-dimensional lung volumetry predicts respiratory complications in patients undergoing major liver resection for colorectal metastases.
Elmaagacli S; Thiele C; Meister F; Menne P; Truhn D; Olde Damink SWM; Bickenbach J; Neumann U; Lang SA; Vondran F; Amygdalos I
Sci Rep; 2024 May; 14(1):10594. PubMed ID: 38719953
[TBL] [Abstract] [Full Text] [Related]
13. Evaluating the utility of
Nakasone ES; Zemla TJ; Yu M; Lin SY; Ou FS; Carter K; Innocenti F; Saltz L; Grady WM; Cohen SA
Epigenetics; 2024 Dec; 19(1):2349980. PubMed ID: 38716804
[TBL] [Abstract] [Full Text] [Related]
14. Predictors for temporary stomas non-closure among non-metastatic rectal cancer patients undergoing curative resection: a retrospective analysis.
Hsu CC; Tsai WS; Tsai TY; You JF; Yeh CY; Hsieh PS; Tang R; Huang SH
World J Surg Oncol; 2024 May; 22(1):124. PubMed ID: 38715036
[TBL] [Abstract] [Full Text] [Related]
15. [Upregulating KLF11 ameliorates intestinal inflammation in mice with 2, 4, 6-trinitrobenesulfonic acid-induced colitis by inhibiting the JAK2/STAT3 signaling pathway].
Xi J; Zhang M; Zhang Y; Zhang C; Zhang Y; Wang R; Shen L; Li J; Song X
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Apr; 44(4):765-772. PubMed ID: 38708511
[TBL] [Abstract] [Full Text] [Related]
16. Short- and long-term outcome differences between patients undergoing left and right colon cancer surgery: cohort study.
Kuliavas J; Marcinkevičiūtė K; Baušys A; Bičkaitė K; Baušys R; Abeciūnas V; Degutytė AE; Kryžauskas M; Stratilatovas E; Dulskas A; Poškus T; Strupas K
Int J Colorectal Dis; 2024 May; 39(1):66. PubMed ID: 38702488
[TBL] [Abstract] [Full Text] [Related]
17. An International Expert-Based Consensus on the Definition of a Clinical Near-Complete Response After Neoadjuvant (Chemo)radiotherapy for Rectal cancer.
Custers PA; Beets GL; Bach SP; Blomqvist LK; Figueiredo N; Gollub MJ; Martling A; Melenhorst J; Ortega CD; Perez RO; Smith JJ; Lambregts DMJ; Beets-Tan RGH; Maas M
Dis Colon Rectum; 2024 Jun; 67(6):782-795. PubMed ID: 38701503
[TBL] [Abstract] [Full Text] [Related]
18. Detailed analysis of metastatic colorectal cancer patients who developed cardiotoxicity on another fluoropyrimidine and switched to S-1 treatment (subgroup analysis of the CardioSwitch-study).
Kinos S; Hagman H; Halonen P; Soveri LM; O'Reilly M; Pfeiffer P; Frödin JE; Sorbye H; Heervä E; Liposits G; Kallio R; Ålgars A; Ristamäki R; Salminen T; Bärlund M; Shah CH; McDermott R; Röckert R; Flygare P; Kwakman J; Teske A; Punt C; Glimelius B; Österlund P
Acta Oncol; 2024 May; 63():248-258. PubMed ID: 38698698
[TBL] [Abstract] [Full Text] [Related]
19. Feasibility of implementation of the early tumor shrinkage as a potential predictive marker to daily clinical practice in patients with RAS wild type metastatic colorectal cancer, treated with cetuximab - a non-interventional observational study.
Fínek J; Vočka M; Bauer J; Kubala E; Zycháčková K; Šedivá M; Gharibyar M; Kocáková I; Čmuchařová E; Vaňková M
Klin Onkol; 2024; 38(2):110-117. PubMed ID: 38697819
[TBL] [Abstract] [Full Text] [Related]
20. Real-world safety and effectiveness of anamorelin for cancer cachexia: Interim analysis of post-marketing surveillance in Japan.
Takayama K; Kojima A; Honda C; Nakayama M; Kanemata S; Endo T; Muro K
Cancer Med; 2024 May; 13(9):e7170. PubMed ID: 38693813
[TBL] [Abstract] [Full Text] [Related]
[Next]
